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• TMAs mediate rapid validation of antibodies against immune markers, 
eliminating the need for single-tissue IHC staining and analysis.
• mIHC paired with TMA utilization could further increase the efficiency 
of validating antibodies. 
Fig 6. Image of Anti-MBP stained WT eye tissue (specific). RET –
retina. ON – optic nerve.
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• Novel immune biomarkers are constantly discovered, sometimes 
replacing old markers for identification.
• Antibodies – including those targeting immune markers – should be 
rigorously validated via methods such as immunohistochemistry 
(IHC) to ensure specificity. 
• Single-tissue IHC staining and analysis is resource and time-
consuming.
• Tissue Microarrays (TMAs) are an efficient platform to implement 
validation using multiple tissues, which allows technical replicates 
and on-slide controls.1,2
Fig 6. Map of TMA design with 60-1mm cores. 
Tissues from WT mice and NSG mice are labeled 
blue and white, respectively. Spln – spleen. Liv –
liver. Lng – lung. Panc – pancreas. Thy - thymus. 
LN – lmph node. Ret – retina. Brn – brain. Kid –
kidney. Hrt – heart. 
Methods:
Methods-cont.:
Fig 7. Panel of Anti-CD20 stained tissues (moderately specific). WT Spleen scanned at 20x (Top 
left). NSG spleen scanned at 20x (Top right). WT kidney scanned at 20x (Bottom left). WT Brain 
scanned at 20x (Bottom right).
Results:
We classified anti-CD20 as moderately specific because while the NSG 
spleen showed positive signal, the NSG kidney showed no signal as 
expected despite the positive signal in the WT kidney. We classified 
anti-CSF1R as moderately specific because the WT spleen showed 
positive signal, as expected, but the NSG spleen showed considerable 
background staining. We classified anti-LAG3 as nonspecific because 
the WT spleen shows positive signal, but the NSG spleen showed more 
positive signal in comparison to the WT spleen. Similarly, we classified 
anti-NCR1 as nonspecific because the WT spleen shows positive 
signal, but the NSG spleen showed more positive signal in comparison 
to the WT spleen. Lastly, we classified anti-FOXP3 as nonspecific 
because both the WT and NSG spleen show similar staining intensity. 
Fig 7. Panel of Anti-LAG3 stained tissues (nonspecific). WT Spleen 




Fig 1. Sample Multiplex Stain of brain tumor border. Rigorous 
antibody validation has significant implications for many procedures, 
such as mIHC. 
Fig 2. (Step 1-3). (1) Image of C57BL/6J (wild-type) mouse. Organs were 
harvested from 3 wild-type (WT) and 3 NSG mice. (2) Paraffin-embedded 
WT mouse liver. Paraffin-embedded single-organ blocks were sectioned. 
(3) Sample QuPath annotation of WT mouse brain. H&E-stained 5μm 
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Fig 3. (Steps 4 -5). (4) Caliper used to measure donor block offset. Offsets of the donor blocks relative to the TMA recipient block were measured 
prior to tissue core extraction. (5) TMA generation using the Galileo semiautomatic tissue microarrayer. Cylindrical tissue cores were extracted 
from single-organ blocks (donor blocks) and inserted into the recipient TMA block.
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Fig 6. (Step 7). Image of Vectra 
Polaris. Slides are scanned on 
H&E, Brightfield preset. 
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Fig 5. (Step 6). Image of H&E stained TMA section.
5 μm sections underwent IHC staining with respective 
antibodies.
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Fig 7. (Step 8). Sample portion of GeneCards 
protein expression profile of CSF1R. IHC-
stained sections are analyzed using existing 
literature, as well as protein and gene expression 
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